High-content screening (HCS), or cellomics, refers to the analytical method that combines automated imaging and quantitative data analysis to evaluate various biochemical and physical characteristics of sample cells. It aids in drug discovery, complex multivariate drug profiling and toxicity studies by utilizing robots, detectors and software to monitor the entire process.
Request for a free sample copy of this report: https://www.imarcgroup.com/high-content-screening-market/requestsample
The key factor driving the global HCS market is the rising cases of chronic diseases like HIV-AIDS, epilepsy, and Parkinson’s diseases, which require intensive treatment. HCS solutions are inexpensive, resource- and time-efficient, and needed for determining the toxicity of chemicals and complex substances in the pharmaceutical industry. Moreover, several leading manufacturers are developing innovative HCS equipment integrated with software platforms and artificial intelligence (AI) systems to enhance the visualization capabilities of the devices. These technological advancements are expected to create a positive outlook for the market in the coming years.
High Content Screening Market 2020-2025 Analysis and Segmentation:
The report has segmented the market on the basis of product, application, end-user and region.
Breakup by Product:
- Cell Imaging and Analysis Systems
- Flow Cytometers
- Reagents & Assay Kits
- Other Consumables
Breakup by Application:
- Target Identification and Validation
- Primary Screening and Secondary Screening
- Toxicity Studies
- Compound Profiling
- Other Applications
Breakup by End-User:
- Pharmaceutical and Biotechnology Companies
- Academic and Government Institutes
- Contract Research Organizations (CROs)
Explore full report with table of contents:
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Becton Dickinson and Company (NYSE: BDX)
- Bio-Rad Laboratories Inc. (NYSE: BIO)
- Biotek Instruments Inc.
- Danaher Corporation (NYSE: DHR)
- GE Healthcare (NYSE: GE)
- Merck Millipore
- Perkinelmer Inc. (NYSE: PKI)
- Tecan Group Ltd. (SWX: TECN)
- Thermo Fisher Scientific (SWX: TECN)
- Yokogawa Electric Corporation (TYO: 6841)
Key highlights of the report:
- Market Performance (2014-2019)
- Market Outlook (2020- 2025)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Report:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1 6317911145
Address:30 N Gould St, Ste R
State: WY 82801
Country: United States